Lpl Financial LLC Immuno Gen, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $67,047 - $161,160	-5,381 Reduced 33.53%	10,666 $316,000
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $31,322 - $44,171	2,223 Added 16.08%	16,047 $254,000
Q2 2023 Jul 31, 2023	SELL	$3.75 - $20.05 $20,291 - $108,490	-5,411 Reduced 28.13%	13,824 $260,000
Q1 2023 May 10, 2023	BUY	$3.67 - $4.92 $28,732 - $38,518	7,829 Added 68.64%	19,235 $73,000
Q4 2022 Feb 07, 2023	SELL	$4.55 - $6.31 $230,594 - $319,790	-50,680 Reduced 81.63%	11,406 $56,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $1,984 - $2,866	443 Added 0.72%	62,086 $297,000
Q2 2022 Aug 12, 2022	BUY	$3.15 - $5.76 $3,496 - $6,393	1,110 Added 1.83%	61,643 $277,000
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $541 - $949	127 Added 0.21%	60,533 $288,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $26,771 - $42,270	5,636 Added 10.29%	60,406 $448,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $96,665 - $126,897	19,256 Added 54.22%	54,770 $311,000
Q2 2021 Aug 13, 2021	BUY	$5.79 - $8.6 $15,100 - $22,428	2,608 Added 7.93%	35,514 $234,000
Q1 2021 May 14, 2021	BUY	$6.5 - $10.53 $2,177 - $3,527	335 Added 1.03%	32,906 $267,000
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $11,980 - $24,803	-3,238 Reduced 9.04%	32,571 $210,000
Q3 2020 Nov 09, 2020	SELL	$3.45 - $4.89 $29,235 - $41,437	-8,474 Reduced 19.14%	35,809 $129,000
Q2 2020 Aug 13, 2020	BUY	$3.32 - $5.34 $47,592 - $76,548	14,335 Added 47.87%	44,283 $204,000
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $4,558 - $14,620	2,150 Added 7.73%	29,948 $102,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $11,126 - $28,681	-4,945 Reduced 15.1%	27,798 $142,000
Q3 2019 Nov 13, 2019	SELL	$2.22 - $3.39 $3,088 - $4,715	-1,391 Reduced 4.08%	32,743 $79,000
Q2 2019 Aug 09, 2019	BUY	$1.8 - $3.3 $896 - $1,643	498 Added 1.48%	34,134 $74,000
Q1 2019 May 08, 2019	SELL	$2.41 - $5.91 $653 - $1,601	-271 Reduced 0.8%	33,636 $91,000
Q4 2018 Feb 07, 2019	BUY	$3.94 - $9.7 $7,911 - $19,477	2,008 Added 6.29%	33,907 $163,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $1,333 - $1,745	-155 Reduced 0.48%	31,899 $302,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $56,862 - $72,571	-5,973 Reduced 15.71%	32,054 $312,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $53,378 - $103,172	-7,967 Reduced 17.32%	38,027 $400,000
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $29,314 - $45,793	-5,782 Reduced 11.17%	45,994 $295,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $279,590 - $438,542	51,776	51,776 $396,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account